Ketamine is used off-label for treatment resistant depression through its non-competitive blockade of the ion channel connected to the NMDA receptor complex on GABA neurons, activation of AMPA receptors and possible ability to increase neuroplasticity and cause downstream activation of the mTOR pathway [13]. The gene discussed is MTOR; the disease is depressive disorder.